T-ALLs arising from cultured ICN1+Arf+/+ donor cells retain the gene but do not express p19Arf protein. (A) Leukemic GFP+ splenocytes from 8 mice that had received cultured (day-12) thymocyte-derived donor cells of the indicated Arf genotypes (top) were purified by FACS. Genomic DNA prepared from these cells was used as a template for PCR performed with primers specific for exon-1β and exon-2 of the Ink4a-Arf locus. Exon-1β encodes the unique N-terminus of p19Arf, whereas exon-2 encodes C-terminal portions of p19Arf and p16Ink4a from alternative reading frames. DNAs extracted from unmanipulated Arf+/+ bone marrow cells and from mouse NIH-3T3 cells that had deleted the Ink4a-Arf locus during the process of immortalization were used as the positive and negative controls, respectively. The fact that no exon-1β signal was revealed in samples 7 and 8 generated from Arf−/− donor cells indicates that the purified leukemic cells were uncontaminated by normal Arf+/+ cells. (B) Although all genotyped leukemias retained the Arf locus, immunoblotting of electrophoretically separated proteins extracted from robustly GFP-positive lymph nodes taken from the same recipients of Arf+/+ donor cells failed to reveal p19Arf expression. Arf expression is also silenced in normal bone marrow (BM) cells. Cells engineered to express Arf conditionally under the control of a metallothionein promoter (MT-Arf cells) were induced with zinc. The immunoblot was developed with a highly sensitive monoclonal antibody generated to mouse p19Arf (Bertwistle et al34 ), and the film was purposely overexposed in an attempt to reveal p19Arf expression. Nucleophosmin (NPM), an abundant nucleolar protein, was used as the loading control. (C) PCR analysis as in panel A. Samples 1 to 4 were taken from irradiated recipients that had received a transplant of uncultured ICN1-expressing bone marrow from 5-FU–conditioned donors. Samples 5 to 10 were taken from nonirradiated recipients that had received 5-FU–conditioned bone marrow transduced with ICN1 and cultured on OP9 stroma before their adoptive transfer. Control PCR reactions were performed using DNAs extracted from unmanipulated Arf+/+ bone marrow cells, NIH-3T3 cells lacking the Ink4a-Arf locus, bone marrow cells from Arf−/− mice in which exon-1β is disrupted, bone marrow cells from p16Ink4a-null mice in which the unique Ink4a exon-1α was disrupted, and from mice in which Ink4a-Arf exon-2 was disrupted. (D) Immunoblotting for p19Arf was performed on bone marrow taken from the mice analyzed in panel C.